Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03XYG
|
||||
Former ID |
DNC012258
|
||||
Drug Name |
1-Methyl-1,3-dihydro-indol-2-one
|
||||
Indication | Discovery agent | Investigative | [526055] | ||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | Inhibitor | [526055] | |
5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [526055] | ||
WikiPathways | Serotonin HTR1 Group and FOS Pathway | ||||
SIDS Susceptibility Pathways | |||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.